Preparation, characterization, antioxidant activities, and determination of anti-Alzheimer effects of PLGA-based DDSs containing ferulic acid

KN Arınmış, HT Kıyan, AA Ozturk - ACS omega, 2024 - ACS Publications
Nanoparticle (NP) systems have attracted the attention of researchers in recent years due to
their advantages, such as modified release features, increased therapeutic efficacy, and …

The role of MoS2 QDs coated with DSPE-PEG-TPP in the protection of protein secondary structure of the brain tissues in an Alzheimer's disease model

OA Alamri, S Qusti, M Balgoon, AA Ageeli… - International Journal of …, 2024 - Elsevier
In this investigation, we have explored the protective capacity of MoS 2 QDs coated with 1, 2-
distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino (polyethyleneglycol)-2000](DSPE …

Nanomaterials-mediated lysosomal regulation: a robust protein-clearance approach for the treatment of Alzheimer's disease

M Hao, J Chu, T Zhang, T Yin, Y Gu… - Neural Regeneration …, 2025 - journals.lww.com
Alzheimer's disease is a debilitating, progressive neurodegenerative disorder characterized
by the progressive accumulation of abnormal proteins, including amyloid plaques and …

Optimization of CNT growth-upheaved nanofilm for highly sensitive fluorescent detection of Alzheimer's disease

Y Jang, J Won, Y Lee, SH Park, J Oh - Sensors and Actuators B: Chemical, 2024 - Elsevier
Alzheimer's disease (AD) is a complex neurological disease that results from the excessive
accumulation of insoluble protein plaques—such as amyloid-beta, tau protein, and beta …

Correction: Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer's disease

K Govindarajan, S Kar - Journal of Nanobiotechnology, 2023 - ncbi.nlm.nih.gov
Correction: Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native
PLGA nanoparticles: implication in the diagnosis of Alzheimer’s disease - PMC Back to Top …